InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Clay Thorp, Director, is a corporate insider tracked by InsiderTape across 3 companies. The public record shows 8 open-market SEC Form 4 transactions: 8 purchases worth $3.9M and 0 sales worth $0, reported from Aug 18, 21 to Feb 24, 25. Over this period they have been a net buyer.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 24, 25 | CLSDClearside Biomedical, Inc. | BUY | 15.0K | $0.92 | $14K |
| Sep 25, 23 | CLSDClearside Biomedical, Inc. | BUY | 10.0K | $0.86 | $9K |
| Dec 21, 22 | CLSDClearside Biomedical, Inc. | BUY | 14.0K | $1.02 | $14K |
| May 17, 22 | VIGLVigil Neuroscience, Inc. | BUY | 14.9K | $2.97 | $44K |
| May 16, 22 | VIGLVigil Neuroscience, Inc. | BUY | 21.8K | $2.76 | $60K |
| Mar 28, 22 | VIGLVigil Neuroscience, Inc. | BUY | 3.0K | $7.20 | $22K |
| Jan 11, 22 | VIGLVigil Neuroscience, Inc. | BUY | 265.0K | $14.00 | $3.7M |
| Aug 18, 21 | PHASPhaseBio Pharmaceuticals Inc | BUY | 10.0K | $3.00 | $30K |